|
|
||||||||
1 Department of Radiology, NYU Medical Center, 560 First Ave., Ste. HW 202, New
York, NY 10016.
2 Department of Radiology, University of Michigan, 1500 E Medical Center Dr.,
Ann Arbor, MI 48109-0030.
OBJECTIVE. Our aim was to evaluate adrenal adenomas in patients who underwent both unenhanced CT and chemical shift MRI to determine if adenomas can be characterized with MRI when the findings of CT are indeterminate.
MATERIALS AND METHODS. Between January 1999 and June 2003, 40 patients (42 adrenal masses) underwent unenhanced CT and chemical shift MRI and were retrospectively analyzed. Hounsfield units, adrenal-to-spleen chemical shift ratio, and signal-intensity index were obtained for each adrenal mass. Qualitative analysis for loss of signal in each adrenal mass on the opposed-phase images was also performed by two reviewers and compared with the quantitative analyses. A lipid-rich adenoma was diagnosed if the mass measured equal to or less than 10 H, had an adrenal-to-spleen chemical shift ratio of less than 0.71, and had a signal-intensity index of greater than 16.5% or if the mass fulfilled two of the preceding criteria and had follow-up imaging without change.
RESULTS. The sensitivities and specificities for diagnosing a lipid-rich adenoma using the qualitative, adrenal-to-spleen chemical shift ratio, signal-intensity index, and unenhanced CT attenuation analyses were 92% (33/36) and 17% (1/6), 100% (36/36) and 100% (6/6), 100% (36/36) and 67% (4/6), and 78% (28/36) and 83% (5/6), respectively. Twenty-eight (67%) lipid-rich adenomas measured equal to or less than 10 H, had an adrenal-to-spleen chemical shift ratio of less than 0.71, and had a signal-intensity index of greater than 16.5%. Eight masses (19%) measured greater than 10 H but had an adrenal-to-spleen chemical shift ratio of less than 0.71 and a signal-intensity index greater than 16.5% and were unchanged at follow-up.
CONCLUSION. Eight (62%) of 13 adrenal adenomas measuring greater than 10 H on unenhanced CT were definitively characterized with chemical shift MRI.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
P. T. Johnson, K. M. Horton, and E. K. Fishman Adrenal Imaging with Multidetector CT: Evidence-based Protocol Optimization and Interpretative Practice RadioGraphics, September 1, 2009; 29(5): 1319 - 1331. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. T. Johnson, K. M. Horton, and E. K. Fishman Adrenal Mass Imaging with Multidetector CT: Pathologic Conditions, Pearls, and Pitfalls RadioGraphics, September 1, 2009; 29(5): 1333 - 1351. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. W. L. Boland, M. A. Blake, P. F. Hahn, and W. W. Mayo-Smith Incidental Adrenal Lesions: Principles, Techniques, and Algorithms for Imaging Characterization Radiology, December 1, 2008; 249(3): 756 - 775. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. T. Schindera, B. J. Soher, D. M. Delong, B. M. Dale, and E. M. Merkle Effect of Echo Time Pair Selection on Quantitative Analysis for Adrenal Tumor Characterization with In-Phase and Opposed-Phase MR Imaging: Initial Experience Radiology, July 1, 2008; 248(1): 140 - 147. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. F. Faria, S. M. Goldman, J. Szejnfeld, H. Melo, C. Kater, P. Kenney, M. P. Huayllas, G. Demarchi, V. V. Francisco, C. Andreoni, et al. Adrenal Masses: Characterization with in Vivo Proton MR Spectroscopy Initial Experience Radiology, December 1, 2007; 245(3): 788 - 797. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. K. Park, C. K. Kim, B. Kim, and J. H. Lee Comparison of Delayed Enhanced CT and Chemical Shift MR for Evaluating Hyperattenuating Incidental Adrenal Masses Radiology, June 1, 2007; 243(3): 760 - 765. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. S. Jhaveri, F. Wong, S. Ghai, and M. A. Haider Comparison of CT histogram analysis and chemical shift MRI in the characterization of indeterminate adrenal nodules. Am. J. Roentgenol., November 1, 2006; 187(5): 1303 - 1308. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |